Skip to main content

Find Clinical Trials

Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,031 public trials 1,839 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Not Yet Recruiting

SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer

NCT07662811

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

NCT07674524

Conditions: ALK Gene Mutation, ALK-positive, Bronchial Neoplasms, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence

NCT07617636

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Research Site São Paulo, Brazil

View Trial Details

Not Yet Recruiting

A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)

NCT07672223

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

NCT07670442

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

NCT07661966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Not Yet Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NCT07488923

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

NYU Langone Health New York, United States

Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Not Yet Recruiting

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

NCT07663630

Conditions: Anorexia, Body Weight, Body Weight Changes, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Feasibility and Preliminary Performance of an AI Prototype for Digital ROSE During EBUS-TBNA and Peripheral TBNA: a Prospective Pilot Study (AI-ROSE-FEAS)

NCT07662967

Conditions: AI (Artificial Intelligence), Bronchoscopy, Disease, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)

NCT07661251

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details